Aviana Molecular Technologies (AMT) is a development stage diagnostic company working on an innovative, highly sensitive, and user friendly platform technology, with an initial interest in developing a point of care diagnostic of infections (POC). AMT believes that its technology can detect specific infections within 15 to 20 minutes and can do so by a non-lab trained health care professional. Such rapid and efficient diagnosis of infections can help in treatment and spread of diseases.
AMT’s technology is simple, adaptable, and can be useful reducing the spread of infections. Conceptually, it can be developed to be used in both highly sophisticated health systems but also in resource-limited environments.
AMT believes that its technology can fill unmet medical needs in the US and around the world, where POC diagnosis can make a difference in human health.